# A RCT of Triple Therapy With Proton Pump Inhibitor vs Vonoprazan for Helicobacter Pylori Gastritis

> **NCT03908619** · PHASE4 · UNKNOWN · sponsor: **Changi General Hospital** · enrollment: 252 (estimated)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** Omeprazole 20mg
- **DRUG:** Esomeprazole 20mg
- **DRUG:** Rabeprazole Sodium 20mg
- **DRUG:** Vonoprazan

## Key facts

- **NCT ID:** NCT03908619
- **Lead sponsor:** Changi General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-04-16
- **Primary completion:** 2021-03-31
- **Final completion:** 2021-03-31
- **Target enrollment:** 252 (ESTIMATED)
- **Last updated:** 2020-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03908619

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03908619, "A RCT of Triple Therapy With Proton Pump Inhibitor vs Vonoprazan for Helicobacter Pylori Gastritis". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT03908619. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*